Siolta Therapeutics
Early stage, venture-backed biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD205m (Public information from Mar 2024)
San Carlos California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
N/A | Series A | ||
$30.0m | Series B | ||
* | N/A | Grant | |
* | $12.0m Valuation: $150m | Series C | |
| Total Funding | CAD57.3m | ||
Related Content
Recent News about Siolta Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.